102 related articles for article (PubMed ID: 19721260)
1. Synthesis and evaluation of pyrrolin-2-one compounds, a series of plasminogen activator inhibitor-1 inhibitors.
Miyazaki H; Ogiku T; Sai H; Moritani Y; Ohtani A; Ohmizu H
Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):979-85. PubMed ID: 19721260
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of pyrrolin-2-one derivatives synthesized by a new practical method as inhibitors of plasminogen activator inhibitor-1 (PAI-1).
Miyazaki H; Miyake T; Terakawa Y; Ohmizu H; Ogiku T; Ohtani A
Bioorg Med Chem Lett; 2010 Jan; 20(2):546-8. PubMed ID: 19969458
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 1,4-diphenylbutadiene derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) production.
Miyazaki H; Sai H; Ohmizu H; Murakami J; Ohtani A; Ogiku T
Bioorg Med Chem; 2010 Mar; 18(5):1968-79. PubMed ID: 20138768
[TBL] [Abstract][Full Text] [Related]
4. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates.
Izuhara Y; Yamaoka N; Kodama H; Dan T; Takizawa S; Hirayama N; Meguro K; van Ypersele de Strihou C; Miyata T
J Cereb Blood Flow Metab; 2010 May; 30(5):904-12. PubMed ID: 20087372
[TBL] [Abstract][Full Text] [Related]
5. New fibrinolytic agents: benzothiophene derivatives as inhibitors of the t-PA-PAI-1 complex formation.
De Nanteuil G; Lila-Ambroise C; Rupin A; Vallez MO; Verbeuren TJ
Bioorg Med Chem Lett; 2003 May; 13(10):1705-8. PubMed ID: 12729646
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis.
Berry CN; Lunven C; Lechaire I; Girardot C; O'Connor SE
Br J Pharmacol; 1998 Sep; 125(1):29-34. PubMed ID: 9776340
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of orally active inhibitors of plasminogen activator inhibitor-1 (PAI-1) production.
Miyazaki H; Ogiku T; Sai H; Ohmizu H; Murakami J; Ohtani A
Bioorg Med Chem Lett; 2008 Dec; 18(24):6419-22. PubMed ID: 18993062
[TBL] [Abstract][Full Text] [Related]
8. A long-acting PAI-1 inhibitor reduces thrombus formation.
Peng S; Xue G; Gong L; Fang C; Chen J; Yuan C; Chen Z; Yao L; Furie B; Huang M
Thromb Haemost; 2017 Jun; 117(7):1338-1347. PubMed ID: 28405670
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and SAR of embelin analogues as the inhibitors of PAI-1 (plasminogen activator inhibitor-1).
Chen F; Zhang G; Hong Z; Lin Z; Lei M; Huang M; Hu L
Bioorg Med Chem Lett; 2014 May; 24(10):2379-82. PubMed ID: 24731276
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the Annonaceous acetogenin, annonacinone, a natural product inhibitor of plasminogen activator inhibitor-1.
Pautus S; Alami M; Adam F; Bernadat G; Lawrence DA; De Carvalho A; Ferry G; Rupin A; Hamze A; Champy P; Bonneau N; Gloanec P; Peglion JL; Brion JD; Bianchini EP; Borgel D
Sci Rep; 2016 Nov; 6():36462. PubMed ID: 27876785
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of piperazine-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1).
Ye B; Chou YL; Karanjawala R; Lee W; Lu SF; Shaw KJ; Jones S; Lentz D; Liang A; Tseng JL; Wu Q; Zhao Z
Bioorg Med Chem Lett; 2004 Feb; 14(3):761-5. PubMed ID: 14741285
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a small molecule PAI-1 inhibitor, ZK4044.
Liang A; Wu F; Tran K; Jones SW; Deng G; Ye B; Zhao Z; Snider RM; Dole WP; Morser J; Wu Q
Thromb Res; 2005; 115(4):341-50. PubMed ID: 15668194
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of new N-acylanthranilic acid derivatives as plasminogen activator inhibitor-1 inhibitors.
Yamaoka N; Kodama H; Izuhara Y; Miyata T; Meguro K
Chem Pharm Bull (Tokyo); 2011; 59(2):215-24. PubMed ID: 21297302
[TBL] [Abstract][Full Text] [Related]
14. [The role of PAI-1 in thrombotic events].
Orbe J; Montes R; Páramo JA
Med Clin (Barc); 1999 Jun; 113(2):63-9. PubMed ID: 10425624
[No Abstract] [Full Text] [Related]
15. [Antithrombotic effects of morpholine and piperazine ring derivatives and their molecular mechanism].
Chen DM; Chen K; Wang H
Yao Xue Xue Bao; 2003 Sep; 38(9):641-5. PubMed ID: 14730909
[TBL] [Abstract][Full Text] [Related]
16. In vitro PAI-1 inhibitory activity of oxalamide derivatives.
Jain MR; Shetty S; Chakrabarti G; Pandya V; Sharma A; Parmar B; Srivastava S; Raviya M; Soni H; Patel PR
Eur J Med Chem; 2008 Apr; 43(4):880-4. PubMed ID: 17664030
[TBL] [Abstract][Full Text] [Related]
17. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
18. Pyrrolo[1,2-f]triazines as JAK2 inhibitors: achieving potency and selectivity for JAK2 over JAK3.
Harikrishnan LS; Kamau MG; Wan H; Inghrim JA; Zimmermann K; Sang X; Mastalerz HA; Johnson WL; Zhang G; Lombardo LJ; Poss MA; Trainor GL; Tokarski JS; Lorenzi MV; You D; Gottardis MM; Baldwin KF; Lippy J; Nirschl DS; Qiu R; Miller AV; Khan J; Sack JS; Purandare AV
Bioorg Med Chem Lett; 2011 Mar; 21(5):1425-8. PubMed ID: 21282055
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and in vitro evaluation of potent, novel, small molecule inhibitors of plasminogen activator inhibitor-1.
Folkes A; Brown SD; Canne LE; Chan J; Engelhardt E; Epshteyn S; Faint R; Golec J; Hanel A; Kearney P; Leahy JW; Mac M; Matthews D; Prisbylla MP; Sanderson J; Simon RJ; Tesfai Z; Vicker N; Wang S; Webb RR; Charlton P
Bioorg Med Chem Lett; 2002 Apr; 12(7):1063-6. PubMed ID: 11909718
[TBL] [Abstract][Full Text] [Related]
20. [2-(O-Phenylalkyl)phenoxy]alkylamines III: Synthesis and selective serotonin-2 receptor binding (2).
Tanaka N; Goto R; Ito R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Fujimoto K
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1729-39. PubMed ID: 11086903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
